4/A//SEC Filing
SHANNON COLIN 4/A
Accession 0001104659-21-087297
CIK 0001613859other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 12:27 PM ET
Size
9.3 KB
Accession
0001104659-21-087297
Insider Transaction Report
Form 4/AAmended
SHANNON COLIN
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2021-06-16$168.13/sh−430$72,296→ 46,500 total - Sale
Common Stock
2021-06-16$167.39/sh−564$94,408→ 46,930 total - Sale
Common Stock
2021-06-16$166.42/sh−7,132$1,186,907→ 47,494 total
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.06 to $167.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3) and (4) of this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.09 to $167.95, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.08 to $168.25, inclusive.
- [F5]The number of shares reported in Column 5 reflects the number of shares beneficially owned by the reporting person as of the filing date of this Form 4, which reflects the transactions reported on the Form 4 filed by the reporting person on June 21, 2021.
Documents
Issuer
PRA Health Sciences, Inc.
CIK 0001613859
Entity typeother
Related Parties
1- filerCIK 0001285101
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 12:27 PM ET
- Size
- 9.3 KB